HK Stock MarketDetailed Quotes

JACOBSON PHARMA (02633)

Watchlist
  • 1.280
  • 0.0000.00%
Market Closed Jan 16 15:38 CST
2.56BMarket Cap8.48P/E (TTM)

JACOBSON PHARMA (02633) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Sep 30, 2025
(FY)Mar 31, 2025
(Q6)Sep 30, 2024
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
Turnover
-5.36%766.55M
7.43%1.58B
13.30%810M
15.79%1.47B
22.86%714.92M
-20.55%1.27B
-22.46%581.89M
10.35%1.6B
7.91%750.41M
-7.99%1.45B
Operating income
-5.36%766.55M
7.43%1.58B
13.30%810M
15.79%1.47B
22.86%714.92M
-20.55%1.27B
-22.46%581.89M
10.35%1.6B
7.91%750.41M
-7.99%1.45B
Cost of sales
6.49%-428.75M
-4.32%-883.96M
-10.80%-458.53M
-16.28%-847.32M
-26.14%-413.84M
25.27%-728.68M
31.30%-328.08M
-10.19%-975.02M
-11.28%-477.57M
-0.38%-884.83M
Operating expenses
6.49%-428.75M
-4.32%-883.96M
-10.80%-458.53M
-16.28%-847.32M
-26.14%-413.84M
25.27%-728.68M
31.30%-328.08M
-10.19%-975.02M
-11.28%-477.57M
-0.38%-884.83M
Gross profit
-3.89%337.8M
11.68%692.94M
16.74%351.47M
15.13%620.48M
18.62%301.08M
-13.15%538.92M
-6.98%253.81M
10.59%620.52M
2.47%272.84M
-18.68%561.08M
Selling expenses
2.58%-61.5M
3.67%-123.97M
2.55%-63.13M
-7.61%-128.69M
-19.09%-64.78M
35.04%-119.59M
38.60%-54.39M
-3.76%-184.09M
3.42%-88.59M
9.15%-177.41M
Administrative expenses
-5.25%-107.49M
1.68%-200.27M
-4.41%-102.13M
-14.22%-203.69M
-25.53%-97.82M
17.46%-178.33M
17.08%-77.93M
6.14%-216.05M
4.83%-93.98M
-11.43%-230.17M
Special items of operating profit
52.46%14.58M
1.93%45.9M
-65.22%9.56M
-37.80%45.03M
-34.25%27.49M
78.74%72.39M
57.18%41.81M
-60.58%40.5M
-62.56%26.6M
241.44%102.74M
Operating profit
-6.33%183.39M
24.46%414.6M
17.96%195.78M
6.30%333.13M
1.64%165.97M
20.12%313.38M
39.72%163.3M
1.81%260.89M
-20.40%116.87M
-19.48%256.24M
Financing cost
37.10%-12.91M
47.44%-41.37M
56.73%-20.53M
-28.16%-78.71M
-142.23%-47.45M
-139.08%-61.41M
-52.25%-19.59M
14.79%-25.69M
18.06%-12.87M
45.55%-30.14M
Share of profits of associates
2,272.87%3.06M
141.21%398K
-61.14%129K
110.14%165K
133.77%332K
54.23%-1.63M
45.84%-983K
3.29%-3.56M
-17.32%-1.82M
-284.45%-3.68M
Share of profit from joint venture company
----
----
----
----
----
----
----
88.49%-213K
83.85%-285K
-35.60%-1.85M
Earning before tax
-1.05%173.54M
46.76%373.63M
47.55%175.38M
1.69%254.58M
-16.72%118.86M
8.17%250.35M
40.06%142.73M
4.93%231.43M
-20.27%101.91M
-16.29%220.57M
Tax
10.22%-31.5M
-63.90%-72.79M
-62.60%-35.09M
-3.35%-44.41M
9.50%-21.58M
1.72%-42.98M
-25.19%-23.84M
-27.62%-43.73M
-23.98%-19.05M
25.55%-34.26M
After-tax profit from continuing operations
1.24%142.04M
43.14%300.83M
44.21%140.29M
1.35%210.17M
-18.17%97.28M
10.48%207.37M
43.48%118.88M
0.75%187.71M
-26.31%82.86M
-14.33%186.31M
After-tax profit from non-continuing business
----
----
----
6.29%80.61M
182.98%80.61M
--75.84M
--28.49M
----
----
-99.82%3K
Earning after tax
1.24%142.04M
3.46%300.83M
-21.14%140.29M
2.67%290.78M
20.71%177.89M
50.88%283.21M
77.85%147.37M
0.75%187.71M
-26.32%82.86M
-14.97%186.31M
Minority profit
----
----
----
-25.98%23.81M
113.40%23.85M
220.40%32.17M
296.31%11.18M
-20.29%10.04M
-71.63%2.82M
262.24%12.6M
Shareholders should account for profits from continuing business
----
43.09%300.83M
----
1.31%210.24M
-9.65%97.31M
--207.51M
--107.71M
----
----
-19.01%173.71M
Shareholders should account for profits from non-continuing business
----
----
----
30.33%56.73M
99.16%56.73M
--43.53M
--28.49M
----
----
-99.74%3K
Profit attributable to shareholders
1.24%142.04M
12.69%300.83M
-8.93%140.29M
6.34%266.97M
13.11%154.04M
41.30%251.04M
70.16%136.19M
2.28%177.67M
-21.92%80.04M
-19.44%173.71M
Basic earnings per share
0.71%0.0712
8.99%0.1515
-12.28%0.0707
5.86%0.139
13.52%0.0806
41.64%0.1313
69.86%0.071
2.21%0.0927
-21.87%0.0418
-16.56%0.0907
Diluted earnings per share
0.71%0.0712
8.99%0.1515
-12.28%0.0707
5.86%0.139
13.52%0.0806
41.64%0.1313
69.86%0.071
2.21%0.0927
-21.87%0.0418
-16.56%0.0907
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
(Q6)Sep 30, 2025(FY)Mar 31, 2025(Q6)Sep 30, 2024(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021
Turnover -5.36%766.55M7.43%1.58B13.30%810M15.79%1.47B22.86%714.92M-20.55%1.27B-22.46%581.89M10.35%1.6B7.91%750.41M-7.99%1.45B
Operating income -5.36%766.55M7.43%1.58B13.30%810M15.79%1.47B22.86%714.92M-20.55%1.27B-22.46%581.89M10.35%1.6B7.91%750.41M-7.99%1.45B
Cost of sales 6.49%-428.75M-4.32%-883.96M-10.80%-458.53M-16.28%-847.32M-26.14%-413.84M25.27%-728.68M31.30%-328.08M-10.19%-975.02M-11.28%-477.57M-0.38%-884.83M
Operating expenses 6.49%-428.75M-4.32%-883.96M-10.80%-458.53M-16.28%-847.32M-26.14%-413.84M25.27%-728.68M31.30%-328.08M-10.19%-975.02M-11.28%-477.57M-0.38%-884.83M
Gross profit -3.89%337.8M11.68%692.94M16.74%351.47M15.13%620.48M18.62%301.08M-13.15%538.92M-6.98%253.81M10.59%620.52M2.47%272.84M-18.68%561.08M
Selling expenses 2.58%-61.5M3.67%-123.97M2.55%-63.13M-7.61%-128.69M-19.09%-64.78M35.04%-119.59M38.60%-54.39M-3.76%-184.09M3.42%-88.59M9.15%-177.41M
Administrative expenses -5.25%-107.49M1.68%-200.27M-4.41%-102.13M-14.22%-203.69M-25.53%-97.82M17.46%-178.33M17.08%-77.93M6.14%-216.05M4.83%-93.98M-11.43%-230.17M
Special items of operating profit 52.46%14.58M1.93%45.9M-65.22%9.56M-37.80%45.03M-34.25%27.49M78.74%72.39M57.18%41.81M-60.58%40.5M-62.56%26.6M241.44%102.74M
Operating profit -6.33%183.39M24.46%414.6M17.96%195.78M6.30%333.13M1.64%165.97M20.12%313.38M39.72%163.3M1.81%260.89M-20.40%116.87M-19.48%256.24M
Financing cost 37.10%-12.91M47.44%-41.37M56.73%-20.53M-28.16%-78.71M-142.23%-47.45M-139.08%-61.41M-52.25%-19.59M14.79%-25.69M18.06%-12.87M45.55%-30.14M
Share of profits of associates 2,272.87%3.06M141.21%398K-61.14%129K110.14%165K133.77%332K54.23%-1.63M45.84%-983K3.29%-3.56M-17.32%-1.82M-284.45%-3.68M
Share of profit from joint venture company ----------------------------88.49%-213K83.85%-285K-35.60%-1.85M
Earning before tax -1.05%173.54M46.76%373.63M47.55%175.38M1.69%254.58M-16.72%118.86M8.17%250.35M40.06%142.73M4.93%231.43M-20.27%101.91M-16.29%220.57M
Tax 10.22%-31.5M-63.90%-72.79M-62.60%-35.09M-3.35%-44.41M9.50%-21.58M1.72%-42.98M-25.19%-23.84M-27.62%-43.73M-23.98%-19.05M25.55%-34.26M
After-tax profit from continuing operations 1.24%142.04M43.14%300.83M44.21%140.29M1.35%210.17M-18.17%97.28M10.48%207.37M43.48%118.88M0.75%187.71M-26.31%82.86M-14.33%186.31M
After-tax profit from non-continuing business ------------6.29%80.61M182.98%80.61M--75.84M--28.49M---------99.82%3K
Earning after tax 1.24%142.04M3.46%300.83M-21.14%140.29M2.67%290.78M20.71%177.89M50.88%283.21M77.85%147.37M0.75%187.71M-26.32%82.86M-14.97%186.31M
Minority profit -------------25.98%23.81M113.40%23.85M220.40%32.17M296.31%11.18M-20.29%10.04M-71.63%2.82M262.24%12.6M
Shareholders should account for profits from continuing business ----43.09%300.83M----1.31%210.24M-9.65%97.31M--207.51M--107.71M---------19.01%173.71M
Shareholders should account for profits from non-continuing business ------------30.33%56.73M99.16%56.73M--43.53M--28.49M---------99.74%3K
Profit attributable to shareholders 1.24%142.04M12.69%300.83M-8.93%140.29M6.34%266.97M13.11%154.04M41.30%251.04M70.16%136.19M2.28%177.67M-21.92%80.04M-19.44%173.71M
Basic earnings per share 0.71%0.07128.99%0.1515-12.28%0.07075.86%0.13913.52%0.080641.64%0.131369.86%0.0712.21%0.0927-21.87%0.0418-16.56%0.0907
Diluted earnings per share 0.71%0.07128.99%0.1515-12.28%0.07075.86%0.13913.52%0.080641.64%0.131369.86%0.0712.21%0.0927-21.87%0.0418-16.56%0.0907
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --KPMG--KPMG--KPMG--KPMG--KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
New Consumption Stocks
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More